109 related articles for article (PubMed ID: 31471250)
1. [Anal channel cancer: customization of dose, volume and breaching].
Peiffert D
Cancer Radiother; 2019 Oct; 23(6-7):773-777. PubMed ID: 31471250
[TBL] [Abstract][Full Text] [Related]
2. [Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].
Troussier I; Huguet F; Servagi-Vernat S; Benahim C; Khalifa J; Darmon I; Ortholan C; Krebs L; Dejean C; Fenoglietto P; Vieillot S; Bensadoun RJ; Thariat J
Cancer Radiother; 2015 Apr; 19(2):127-38. PubMed ID: 25770884
[TBL] [Abstract][Full Text] [Related]
3. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
[TBL] [Abstract][Full Text] [Related]
4. [Anal canal cancer: In the era of intensity-modulated radiotherapy, outstanding issues].
Peiffert D; Baumann AS; Serre AA; Vendrely V; Rouard N; Faivre JC; Vogin G
Cancer Radiother; 2018 Oct; 22(6-7):509-514. PubMed ID: 30181029
[TBL] [Abstract][Full Text] [Related]
5. Trends in Radiation Dose and Technique For Anal Canal Squamous Cell Carcinoma.
Wegner RE; Abel S; Hasan S; White RJ; Raj M; Monga D; Finley G; McCormick J; Kirichenko AV
Am J Clin Oncol; 2019 Jun; 42(6):519-526. PubMed ID: 31136369
[TBL] [Abstract][Full Text] [Related]
6. Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT.
Dell'Acqua V; Kobiela J; Kraja F; Leonardi MC; Surgo A; Zerella MA; Arculeo S; Fodor C; Ricotti R; Zampino MG; Ravenda S; Spinoglio G; Biffi R; Bazani A; Luraschi R; Vigorito S; Spychalski P; Orecchia R; Glynne-Jones R; Jereczek-Fossa BA
Med Oncol; 2018 Mar; 35(5):59. PubMed ID: 29594584
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
[TBL] [Abstract][Full Text] [Related]
8. Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule.
Lestrade L; Zilli T; Kountouri M; Jumeau R; Matzinger O; Bourhis J; Miralbell R; Ozsahin M; De Bari B
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):e105-e109. PubMed ID: 28222958
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy of anal canal cancer.
Peiffert D; Huguet F; Vendrely V; Moureau-Zabotto L; Rivin Del Campo E; Créhange G; Dietmann AS; Moignier A
Cancer Radiother; 2022; 26(1-2):279-285. PubMed ID: 34955416
[TBL] [Abstract][Full Text] [Related]
10. [The treatment of squamous cell cancer of the anal canal].
Knysh VI; Timofeev IuM
Vopr Onkol; 1991; 37(9-10):981-5. PubMed ID: 1842662
[TBL] [Abstract][Full Text] [Related]
11. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
[TBL] [Abstract][Full Text] [Related]
12. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
13. Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study).
Ortholan C; Resbeut M; Hannoun-Levi JM; Teissier E; Gerard JP; Ronchin P; Zaccariotto A; Minsat M; Benezery K; François E; Salem N; Ellis S; Azria D; Champetier C; Gross E; Cowen D
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1988-95. PubMed ID: 21570207
[TBL] [Abstract][Full Text] [Related]
14. Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control.
Zilli T; Betz M; Bieri S; Ris F; Roche B; Roth AD; Allal AS
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):60-6. PubMed ID: 23608237
[TBL] [Abstract][Full Text] [Related]
15. Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications.
Peiffert D; Bey P; Pernot M; Guillemin F; Luporsi E; Hoffstetter S; Aletti P; Boissel P; Bigard MA; Dartois D; Baylac F
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):313-24. PubMed ID: 9069302
[TBL] [Abstract][Full Text] [Related]
16. [Intensity-modulated radiation therapy for anal carcinoma].
Peiffert D; Moreau-Claeys MV; Tournier-Rangeard L; Huger S; Marchesi V
Cancer Radiother; 2011 Oct; 15(6-7):549-54. PubMed ID: 21855384
[TBL] [Abstract][Full Text] [Related]
17. Treatment of the Primary Tumor in Anal Canal Cancers.
Glynne-Jones R; Rao S
Surg Oncol Clin N Am; 2017 Jan; 26(1):73-90. PubMed ID: 27889038
[TBL] [Abstract][Full Text] [Related]
18. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.
Ng M; Leong T; Chander S; Chu J; Kneebone A; Carroll S; Wiltshire K; Ngan S; Kachnic L
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1455-62. PubMed ID: 22401917
[TBL] [Abstract][Full Text] [Related]
19. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
20. Interstitial high-dose rate brachytherapy as boost for anal canal cancer.
Falk AT; Claren A; Benezery K; François E; Gautier M; Gerard JP; Hannoun-Levi JM
Radiat Oncol; 2014 Nov; 9():240. PubMed ID: 25377886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
